SIGN UP
LOG IN
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·04/24/2025 17:05:54
Listen to the news
Gainers
- CERo Therapeutics Hldgs (NASDAQ:CERO) stock moved upwards by 37.6% to $1.1 during Thursday's regular session. The company's market cap stands at $5.9 million.
- TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 26.43% to $0.4. The market value of their outstanding shares is at $9.2 million.
- Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 24.8% to $9.76. The market value of their outstanding shares is at $462.5 million.
- Community Health Sys (NYSE:CYH) shares increased by 24.69% to $3.03. The market value of their outstanding shares is at $420.9 million. As per the press release, Q1 earnings came out yesterday.
- BioSig Technologies (NASDAQ:BSGM) shares increased by 23.43% to $0.79. The market value of their outstanding shares is at $19.1 million.
- Jaguar Health (NASDAQ:JAGX) shares moved upwards by 19.94% to $8.0. The market value of their outstanding shares is at $5.3 million.
Losers
- NuCana (NASDAQ:NCNA) shares decreased by 26.3% to $0.66 during Thursday's regular session. The company's market cap stands at $3.9 million.
- Intensity Therapeutics (NASDAQ:INTS) shares decreased by 23.85% to $0.99. The company's market cap stands at $15.0 million.
- Ensysce Biosciences (NASDAQ:ENSC) shares declined by 16.08% to $3.08. The company's market cap stands at $5.0 million.
- Metsera (NASDAQ:MTSR) stock fell 15.17% to $20.0. The company's market cap stands at $2.1 billion.
- Catheter Precision (AMEX:VTAK) stock declined by 12.5% to $0.28. The market value of their outstanding shares is at $2.2 million.
- Plus Therapeutics (NASDAQ:PSTV) shares decreased by 11.41% to $0.87. The market value of their outstanding shares is at $5.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.